Peppermint Raises $4.7 Million in Seed Funding
Peppermint, a San Francisco-based company that specializes in AI-powered financial operations for clinical research sites, has successfully raised $4.7 million in a seed funding round. The funding round was led by Moxxie, with participation from investors such as Homebrew, Better Tomorrow Ventures, Layout Ventures, Digital Health Venture Partners, Night Capital, Benjamin Mann, and Evan Moore.
Company Overview
Founded by David Freeman and Vijay Thirumalai, Peppermint provides a platform that uses expert billers and automation to handle financial operations for clinical research sites. The platform is designed to capture, invoice, collect, and reconcile the revenue earned by these sites, streamlining financial processes and improving efficiency.
Use of Funds
With the newly secured funds, Peppermint plans to enhance its platform's capabilities and expand its market reach. The company aims to invest in technology development and possibly increase its workforce to support growth initiatives.
Investors and Leadership
The seed round was spearheaded by Moxxie, a notable investor in the tech sector, alongside other significant contributors like Homebrew and Better Tomorrow Ventures. The involvement of these investors highlights the confidence in Peppermint's innovative approach to financial operations in the clinical research industry.
David Freeman and Vijay Thirumalai, the co-founders, bring substantial expertise to the company, guiding its strategic direction and ensuring the platform meets the evolving needs of its users.